Using f2 for compounds that never reach 85% dissolution [Dissolution / BCS / IVIVC]

posted by nobody – 2017-01-03 20:19 (3107 d 07:14 ago) – Posting: # 16924
Views: 6,663

Hi!

As the experts are apparently still on holiday :-) I might start with some questions/remarks.

Liposomes with doxorubicin (just wild guessing here ;-) ) are no oral formulation afaik. Why would you do dissolution testing (simulation GI tract, normally)?

The fraction of dose you get into solution pretty much depends on the media you use for your testing, in my opinion.

So maybe some more details on the kind of products/projects your on might be helpful to get more response. :-)

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,687 registered users;
80 visitors (0 registered, 80 guests [including 14 identified bots]).
Forum time: 04:33 CEST (Europe/Vienna)

Anyone who conducts an argument by appealing to authority
is not using his intelligence;
he is just using his memory.    Leonardo da Vinci

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5